mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes
International Journal of Molecular Sciences · 08.08.2024 · 25 (16) · 8676
DOI: 10.3390/ijms25168676 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.08.2024. Verfasst von Dario Troise und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, Univ…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, TOR Serine-Threonine Kinases, Aging, Drug Synergism. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Abstract (Originalsprache)
The aging process contributes significantly to the onset of chronic diseases, which are the primary causes of global mortality, morbidity, and healthcare costs. Numerous studies have shown that the removal of senescent cells from tissues extends lifespan and reduces the occurrence of age-related diseases. Consequently, there is growing momentum in the development of drugs targeting these cells. Among them, mTOR and SGLT-2 inhibitors have garnered attention due to their diverse effects: mTOR inhibitors regulate cellular growth, metabolism, and immune responses, while SGLT-2 inhibitors regulate glucose reabsorption in the kidneys, resulting in various beneficial metabolic effects. Importantly, these drugs may act synergistically by influencing senescence processes and pathways. Although direct studies on the combined effects of mTOR inhibition and SGLT-2 inhibition on age-related processes are limited, this review aims to highlight the potential synergistic benefits of these drugs in targeting senescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
- Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14152 Stockholm, Sweden.
- Unit of Clinical Pathology, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
ORCID-Profile: Dario Troise, Giuseppe Stefano Netti, Elena Ranieri
Förderung
- Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy
Zitieren
APA
Troise, D., Mercuri, S., Infante, B., Losappio, V., Cirolla, L., Netti, G. S., Ranieri, E., & Stallone, G. (2024). mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes. International Journal of Molecular Sciences, 25(16), 8676. https://doi.org/10.3390/ijms25168676
Vancouver
Troise D, Mercuri S, Infante B, Losappio V, Cirolla L, Netti GS, et al. mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes. International Journal of Molecular Sciences. 2024;25(16):8676. doi:10.3390/ijms25168676
BibTeX
@article{Troise2024,
author = {Troise, Dario and Mercuri, Silvia and Infante, Barbara and Losappio, Vincenzo and Cirolla, Luciana and Netti, Giuseppe Stefano and Ranieri, Elena and Stallone, Giovanni},
title = {mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {8676},
doi = {10.3390/ijms25168676}
}
EUVIMED